Protective Effect of Quercetin against Oxidative Stress and Brain Edema in an Experimental Rat Model of Subarachnoid Hemorrhage

Yushu Dong, Ju-lei Wang, Dayun Feng, Huaizhou Qin, Wen Hua, Zhongmin Yin, Guodong Gao, Chuan LiInternational Journal of Medical Sciences 2014 · DOI

Abstract

Quercetin has been demonstrated to play an important role in altering the progression of ischemic brain injuries and neurodegenerative diseases by protecting against oxidative stress. The effects of quercetin on brain damage after subarachnoid hemorrhage (SAH), however, have not been investigated. This study was designed to explore the effects of quercetin on oxidative stress and brain edema after experimental SAH using four equal groups (n = 16) of adult male Sprague-Dawley (SD) rats, including a sham group, an SAH + vehicle group, an SAH + quercetin10 group, and an SAH + quercetin50 group. The rat SAH model was induced by injection of 0.3 ml of non-heparinised arterial blood into the prechiasmatic cistern. In the SAH + quercetin10 and SAH + quercetin50 groups, doses of 10 mg/kg and 50 mg/kg quercetin, respectively, were directly administered by intraperitoneal injection at 30 min, 12 h, and 24 h after SAH induction. Cerebral tissue samples were extracted for enzymatic antioxidant determination, lipid peroxidation assay, caspase-3 activity and water content testing 48 h after SAH. Treatment with a high dose (50 mg/kg) of quercetin markedly enhanced the activities of copper/zinc superoxide dismutase (CuZn-SOD) and glutathione peroxidase (GSH-Px), and treatment with this dose significantly reduced the level of malondialdehyde (MDA). Caspase-3 and brain edema was ameliorated and neurobehavioral deficits improved in rats that received the high dose of quercetin. The findings suggest that the early administration of optimal dose of quercetin may ameliorate brain damage and provide neuroprotection in the SAH model, potentially by enhancing the activity of endogenous antioxidant enzymes and inhibiting free radical generation.

Introduction

Subarachnoid hemorrhage (SAH), frequently resulting from a ruptured cerebral aneurysm, is a critical medical emergency characterized by high rates of mortality and long-term disability. While the primary hemorrhage causes immediate damage, significant morbidity is attributed to "secondary brain injury" that evolves in the hours and days following the initial event.

A central mechanism of this secondary injury is oxidative stress. This occurs when reactive oxygen species (ROS) production exceeds the capacity of endogenous antioxidant defenses, leading to lipid peroxidation, cellular apoptosis, and brain edema. Quercetin, a naturally occurring flavonoid found in various fruits and vegetables, is known for its potent antioxidant properties. This study investigates whether quercetin can mitigate the acute neurological and biochemical damage following SAH.

Methods

The study utilized an experimental rat model of SAH, induced by injecting autologous arterial blood into the prechiasmatic cistern of adult male Sprague-Dawley rats. Subjects were randomized into four groups:

  1. Sham: Surgical procedures without hemorrhage.
  2. SAH + Vehicle: Hemorrhage followed by saline treatment.
  3. SAH + Quercetin10: Hemorrhage followed by 10 mg/kg quercetin.
  4. SAH + Quercetin50: Hemorrhage followed by 50 mg/kg quercetin.

Quercetin was administered intraperitoneally at 30 minutes, 12 hours, and 24 hours post-induction. Assessments at 48 hours included neurological scoring (0–6 scale), brain water content analysis, and biochemical assays for antioxidant enzyme activity (SOD, GSH-Px) and lipid peroxidation (MDA). Apoptotic markers, specifically Caspase-3, were evaluated in the hippocampus via Western blotting and immunohistochemistry.

Results

Neurological Recovery

A significant finding was the dose-dependent nature of quercetin's neuroprotective effects. While the 10 mg/kg dose showed negligible improvement, the 50 mg/kg dose significantly enhanced neurological outcomes. Rats in the high-dose group exhibited lower neurobehavioral scores, indicating reduced physical and functional deficits compared to the untreated SAH group.

Neurobehavioral scores across experimental groups at 48 hours post-SAH. Lower scores indicate better neurological performance.

Oxidative Stress and Antioxidant Activity

Quercetin treatment at 50 mg/kg effectively bolstered the brain's internal antioxidant defenses. There was a marked increase in the activities of CuZn-SOD and GSH-Px compared to the vehicle-treated SAH group. Concurrently, levels of malondialdehyde (MDA), a primary marker of lipid peroxidation and oxidative damage, were significantly reduced in the high-dose group.

Biochemical markers of oxidative stress in cerebral tissue: (A) CuZn-SOD activity, (B) GSH-Px activity, and (C) MDA levels.

Brain Edema and Apoptosis

High-dose quercetin also addressed critical physiological complications. Brain water content, a measure of edema, was reduced from 83.19% in the vehicle group to 78.83% in the 50 mg/kg group. Furthermore, quercetin treatment led to a significant decrease in Caspase-3 activity, particularly in the CA1 region of the hippocampus, suggesting a reduction in programmed cell death.

Discussion and Conclusion

This study demonstrates that early administration of high-dose quercetin (50 mg/kg) provides significant neuroprotection in a rat model of SAH. The mechanism appears to involve both the direct reduction of oxidative stress markers and the upregulation of endogenous antioxidant enzymes.

However, several limitations warrant further study. The current research focused on a narrow 48-hour window; long-term cognitive and survival outcomes remain to be determined. Additionally, the precise molecular pathways, such as the potential involvement of the Nrf2 signaling pathway, require more detailed investigation. While these preclinical results are promising, clinical translation will necessitate rigorous human trials to establish safety and efficacy in a clinical setting.

Summary updated

Abstract

Quercetin has been demonstrated to play an important role in altering the progression of ischemic brain injuries and neurodegenerative diseases by protecting against oxidative stress. The effects of quercetin on brain damage after subarachnoid hemorrhage (SAH), however, have not been investigated. This study was designed to explore the effects of quercetin on oxidative stress and brain edema after experimental SAH using four equal groups (n = 16) of adult male Sprague-Dawley (SD) rats, including a sham group, an SAH + vehicle group, an SAH + quercetin10 group, and an SAH + quercetin50 group. The rat SAH model was induced by injection of 0.3 ml of non-heparinised arterial blood into the prechiasmatic cistern. In the SAH + quercetin10 and SAH + quercetin50 groups, doses of 10 mg/kg and 50 mg/kg quercetin, respectively, were directly administered by intraperitoneal injection at 30 min, 12 h, and 24 h after SAH induction. Cerebral tissue samples were extracted for enzymatic antioxidant determination, lipid peroxidation assay, caspase-3 activity and water content testing 48 h after SAH. Treatment with a high dose (50 mg/kg) of quercetin markedly enhanced the activities of copper/zinc superoxide dismutase (CuZn-SOD) and glutathione peroxidase (GSH-Px), and treatment with this dose significantly reduced the level of malondialdehyde (MDA). Caspase-3 and brain edema was ameliorated and neurobehavioral deficits improved in rats that received the high dose of quercetin. The findings suggest that the early administration of optimal dose of quercetin may ameliorate brain damage and provide neuroprotection in the SAH model, potentially by enhancing the activity of endogenous antioxidant enzymes and inhibiting free radical generation.
BibTeX
@article{dong2014protective,
  author = {Yushu Dong and Ju-lei Wang and Dayun Feng and Huaizhou Qin and Wen Hua and Zhongmin Yin and Guodong Gao and Chuan Li},
  title = {{Protective Effect of Quercetin against Oxidative Stress and Brain Edema in an Experimental Rat Model of Subarachnoid Hemorrhage}},
  journal = {International Journal of Medical Sciences},
  year = {2014},
  doi = {10.7150/ijms.7634},
}
Figure